Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Nxera Pharma - Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals
Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals
GlobeNewswire

Tokyo, Japan and Cambridge, UK, 5 March 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that Centessa Pharmaceuticals has achieved an additional early development milestone…

fool.com - Motley Fool Transcribing - Atea Pharma (AVIR) Earnings Call Transcript
Atea Pharma (AVIR) Earnings Call Transcript
The Motley Fool

Thursday, March 5, 2026 at 4:30 p.m. ET Chief Executive Officer — Jean-Pierre Sommadossi Chief Medical Officer — Dr. Janet Hammond Chief Development Officer — Dr. Arantxa Horga Chief Commercial Officer — John F. Vavricka…

globenewswire.com - Zealand Pharma - Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity
Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity
GlobeNewswire

Company announcement – No. 3 / 2026 Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity Petrelintide…

thehindu.com - The Hindu Bureau - War can impact up to ₹5,000 cr. of pharma exports, disrupt supply chain
War can impact up to ₹5,000 cr. of pharma exports, disrupt supply chain
The Hindu

Pharmaceutical exports, particularly to GCC and WANA regions, are likely to be impacted significantly amid challenges triggered by the war in West Asia, the uncertainty over cargo movement being the foremost, the Pharmaceuticals Export Promotion…

nypost.com - Katherine Donlevy - Walgreens workers will wear bodycams in some NYC stores but shoppers don't want to be pharma seen
Walgreens workers will wear bodycams in some NYC stores but shoppers don't want to be pharma seen
New York Post

Walgreens will equip employees with body cameras in an apparent first in the city — but “Big Brother” weary New Yorkers say they don't want to be pharma seen. The pharmacy store giant — which also owns Duane Reade…

law360.com - Emilie Ruscoe - Fintech Sues Deutsche Bank, Pathward Over Pharma Flags
Fintech Sues Deutsche Bank, Pathward Over Pharma Flags
Law360

A self-described barter-based payment platform sued Deutsche Bank AG and Pathward NA, alleging it was improperly placed on an industry blacklist following the banks' assertions it was 'transaction laundering' for companies... To view the full…

thehindubusinessline.com - Global freight market challenges will have adverse impact on pharma exports: Pharmexcil
Global freight market challenges will have adverse impact on pharma exports: Pharmexcil
BusinessLine

The ongoing challenges in the global freight market have the potential to significantly impact Indian pharmaceutical exports, particularly in regions like GCC countries and West Asia- North Africa (WANA) according to Pharmaceuticals Export…

thehindubusinessline.com - Swiss pharma group Lonza to set up new GCC in Hyderabad
Swiss pharma group Lonza to set up new GCC in Hyderabad
BusinessLine

Lonza Group AG, a global contract development and manufacturing organisation (CDMO), will establish a new Global Capability Centre (GCC) in Hyderabad. A delegation from the company met Minister for Industries D Sridhar Babu and CEO of Telangana…

bizwest.com - Christopher Wood - Corden Pharma leases 5505 Central spec building in Boulder
Corden Pharma leases 5505 Central spec building in Boulder
BizWest

BOULDER — Corden Pharma Colorado Inc., a developer and manufacturer of peptide drug substances, has leased the 64,000-square-foot 5505 Central building in Flatiron Park, the latest move in the company's rapid expansion in Boulder. The…

marketbeat.com - aTyr Pharma (NASDAQ:ATYR) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS
aTyr Pharma (NASDAQ:ATYR) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS
MarketBeat

aTyr Pharma (NASDAQ:ATYR - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.14) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.18) by $0.04, FiscalAI reports. ATYR…

marketbeat.com - aTyr Pharma (ATYR) Expected to Announce Quarterly Earnings on Thursday
aTyr Pharma (ATYR) Expected to Announce Quarterly Earnings on Thursday
MarketBeat

aTyr Pharma (NASDAQ:ATYR - Get Free Report) will likely be announcing its Q4 2025 results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of ($0.18) per share and revenue of $0.02 million for the…

marketbeat.com - Royalty Pharma (NASDAQ:RPRX) Reaches New 12-Month High - Still a Buy?
Royalty Pharma (NASDAQ:RPRX) Reaches New 12-Month High - Still a Buy?
MarketBeat

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) shares reached a new 52-week high on Thursday. The stock traded as high as $47.86 and last traded at $47.43, with a volume of 4344628 shares. The stock had previously closed at $47.48. How Royalty…

globenewswire.com - Orion Oyj - Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire

STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the…

bloomberg.com - Stock Movers: Broadcom, Sable Offshore, Roche
Stock Movers: Broadcom, Sable Offshore, Roche
Bloomberg

Stock Movers • Browse all episodes Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg…

marketbeat.com - Insider Selling: Teva Pharmaceutical Industries (NYSE:TEVA) CEO Sells 442,935 Shares of Stock
Insider Selling: Teva Pharmaceutical Industries (NYSE:TEVA) CEO Sells 442,935 Shares of Stock
MarketBeat

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) CEO Richard Francis sold 442,935 shares of the company's stock in a transaction on Tuesday, March 3rd. The stock was sold at an average price of $32.36, for a total value of…

Receive a Daily briefing on Pharma Industry News

Get Started